Global Oncology Cancer Drugs Market Report - Industry Trend & Analysis, Size, Share, Geography, Forecast, 2019 - 2027

Table of Content

Chapter 1       Introduction

  • Report Description
  • Scope of the Market
  • Research Methodology

Chapter 2       Executive Summary

  • Snapshot of the Market
  • Primary Interview Details

Chapter 3       Market Overview

  • Market Introduction and Scope
  • Porter’s Five Forces Analysis
  • PEST Analysis
  • Key Trends and Future Outlook
  • Competitive Landscape: Company Market Share Analysis
  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities

Chapter 4       Market Segments by Indication (Revenue, USD Billion, 2019 - 2027)

  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Other Cancers

Chapter 5       Market Segments by Region (Revenue, USD Billion, 2019 - 2027)

  • North America
    • The U.S.
    • Mexico
    • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Belgium
      • Switzerland
      • Netherlands
      • Rest of Europe
      • Asia Pacific
        • China
        • Japan
        • India
        • South Korea
        • Taiwan
        • Singapore
        • Australia
        • Rest of Asia Pacific
        • Rest of the World (RoW)
          • Central & South America
          • Middle East
          • Africa

Chapter 6       Company Profiles (Overview, Business Strategies, Financials, Recent Developments)

  • AbbVie Inc
  • Amgen
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson (Janssen Global Services, LLC,)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc
  • Others
Back to top

Payment Options

Single User : $3,599
Five User: $5,175
Enterprise : $9,135
Datapack : $1,299
Short Report : $1,799